BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

733 related articles for article (PubMed ID: 30972074)

  • 1. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity.
    Valatas V; Kolios G; Bamias G
    Front Immunol; 2019; 10():583. PubMed ID: 30972074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.
    Siakavellas SI; Bamias G
    Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Death Receptor 3 Signaling Controls the Balance between Regulatory and Effector Lymphocytes in SAMP1/YitFc Mice with Crohn's Disease-Like Ileitis.
    Li Z; Buttó LF; Buela KA; Jia LG; Lam M; Ward JD; Pizarro TT; Cominelli F
    Front Immunol; 2018; 9():362. PubMed ID: 29545797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation.
    Meylan F; Richard AC; Siegel RM
    Immunol Rev; 2011 Nov; 244(1):188-96. PubMed ID: 22017439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Experimental Crohn's Disease.
    Buttó LF; Jia LG; Arseneau KO; Tamagawa H; Rodriguez-Palacios A; Li Z; De Salvo C; Pizarro TT; Bamias G; Cominelli F
    Inflamm Bowel Dis; 2019 Jan; 25(1):14-26. PubMed ID: 30295722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Role for TL1A/DR3 in Protection against Intestinal Injury and Infection.
    Jia LG; Bamias G; Arseneau KO; Burkly LC; Wang EC; Gruszka D; Pizarro TT; Cominelli F
    J Immunol; 2016 Jul; 197(1):377-86. PubMed ID: 27233964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor necrosis factor-like cytokine 1A/death receptor 3 cytokine system in intestinal inflammation.
    Bamias G; Jia LG; Cominelli F
    Curr Opin Gastroenterol; 2013 Nov; 29(6):597-602. PubMed ID: 24100723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo.
    Jacob N; Kumagai K; Abraham JP; Shimodaira Y; Ye Y; Luu J; Blackwood AY; Castanon SL; Stamps DT; Thomas LS; Gonsky R; Shih DQ; Michelsen KS; Targan SR
    Sci Rep; 2020 Oct; 10(1):18189. PubMed ID: 33097818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.
    Takedatsu H; Michelsen KS; Wei B; Landers CJ; Thomas LS; Dhall D; Braun J; Targan SR
    Gastroenterology; 2008 Aug; 135(2):552-67. PubMed ID: 18598698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation.
    Meylan F; Song YJ; Fuss I; Villarreal S; Kahle E; Malm IJ; Acharya K; Ramos HL; Lo L; Mentink-Kane MM; Wynn TA; Migone TS; Strober W; Siegel RM
    Mucosal Immunol; 2011 Mar; 4(2):172-85. PubMed ID: 20980995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of TL1A and its receptor DR3 in two models of chronic murine ileitis.
    Bamias G; Mishina M; Nyce M; Ross WG; Kollias G; Rivera-Nieves J; Pizarro TT; Cominelli F
    Proc Natl Acad Sci U S A; 2006 May; 103(22):8441-6. PubMed ID: 16698931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells.
    Richard AC; Tan C; Hawley ET; Gomez-Rodriguez J; Goswami R; Yang XP; Cruz AC; Penumetcha P; Hayes ET; Pelletier M; Gabay O; Walsh M; Ferdinand JR; Keane-Myers A; Choi Y; O'Shea JJ; Al-Shamkhani A; Kaplan MH; Gery I; Siegel RM; Meylan F
    J Immunol; 2015 Apr; 194(8):3567-82. PubMed ID: 25786692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease.
    Bamias G; Martin C; Marini M; Hoang S; Mishina M; Ross WG; Sachedina MA; Friel CM; Mize J; Bickston SJ; Pizarro TT; Wei P; Cominelli F
    J Immunol; 2003 Nov; 171(9):4868-74. PubMed ID: 14568967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Levels of Tl1a Affect the Expansion and Function of Regulatory T Cells in Modulating Murine Colitis.
    Sidhu-Varma M; Shih DQ; Targan SR
    Inflamm Bowel Dis; 2016 Mar; 22(3):548-59. PubMed ID: 26818423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble TL1A is sufficient for activation of death receptor 3.
    Bittner S; Knoll G; Füllsack S; Kurz M; Wajant H; Ehrenschwender M
    FEBS J; 2016 Jan; 283(2):323-36. PubMed ID: 26509650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of TL1A and DR3 in autoimmune and inflammatory diseases.
    Aiba Y; Nakamura M
    Mediators Inflamm; 2013; 2013():258164. PubMed ID: 24453414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis.
    Castellanos JG; Woo V; Viladomiu M; Putzel G; Lima S; Diehl GE; Marderstein AR; Gandara J; Perez AR; Withers DR; Targan SR; Shih DQ; Scherl EJ; Longman RS
    Immunity; 2018 Dec; 49(6):1077-1089.e5. PubMed ID: 30552020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crohn's disease-associated mucosal factors regulate the expression of TNF-like cytokine 1A and its receptors in primary subepithelial intestinal myofibroblasts and intestinal epithelial cells.
    Bamias G; Filidou E; Goukos D; Valatas V; Arvanitidis K; Panagopoulou M; Kouklakis G; Daikos GL; Ladas SD; Kolios G
    Transl Res; 2017 Feb; 180():118-130.e2. PubMed ID: 27665176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients.
    Ślebioda TJ; Bojarska-Junak A; Stanisławowski M; Cyman M; Wierzbicki PM; Roliński J; Celiński K; Kmieć Z
    Scand J Immunol; 2015 Oct; 82(4):352-60. PubMed ID: 26072972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.